journal article·2024-02-14Open access

Formation of a Controllable Diffusion Barrier Layer on the Surface of Polydimethylsiloxane Films by Infrared Laser Irradiation

Hung Quoc Tran, Asad ur Rehman, Philippe Fioux, Aissam Airoudj, Thierry Vandamme, Valeriy Luchnikov

Abstract

Developing a diffusion barrier layer on material interfaces has potential applications in various fields such as in packaging materials, pharmaceuticals, chemical filtration, microelectronics, and medical devices. Although numerous physical and chemical methods have been proposed to generate the diffusion barrier layer, the complexity of fabrication techniques and the high manufacturing costs limit their practical utility. Here, we propose an innovative approach to fabricate the diffusion barrier layer by irradiating poly(dimethylsiloxane) (PDMS) with a mid-infrared (λ = 10.6 μm) CO 2 laser. This process directly creates a diffusion barrier layer on the PDMS surface by forming a heavily cross-linked network in the polymer matrix. The optimal irradiation conditions were investigated by modulating the defocusing distance, laser power, and number of scanning passes. The barrier thickness can reach up to 70 μm as observed by the scanning electron microscope (SEM). The attenuated total reflectance (ATR), electron dispersive X-ray (EDX), and X-ray photoelectron spectroscopy (XPS) analyses collectively confirmed the formation of the SiO x structure on the modified surface based on the decreased methyl group signal and the increased oxygen/silicon ratio. The diffusion test with the model drugs (rhodamine B and donepezil) demonstrated that the modified surface exhibits effective diffusion barrier properties and the rate of drug diffusion through the modified barrier layer can be controlled by the optimization of the irradiation parameters. This novel approach provides the possibility to develop a controllable diffusion barrier layer in a biocompatible polymer with prospective applications in the fields of pharmaceuticals, packing materials, and medical devices.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Microfluidic and Capillary Electrophoresis Applications · Surface Modification and Superhydrophobicity · Analytical Chemistry and Sensors

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institut de Science des Matériaux de Mulhouse, CNRS LRC 7361, 68057 Mulhouse, France

INSERM, Regenerative Nanomedicine UMR 1260, Centre de Recherche en Biomédecine de Strasbourg (CRBS), Université de Strasbourg, F-67000 Strasbourg, France

Funding

Agence Nationale de la Recherche

References (50)

Show source-provided references
1. 10.1147/rd.425.060710.1147/rd.425.0607 ↗
2. 10.1039/c3gc40291f10.1039/c3gc40291f ↗
3. 10.1016/j.memsci.2006.05.01110.1016/j.memsci.2006.05.011 ↗
4. 10.3390/separations905011610.3390/separations9050116 ↗
5. 10.1016/j.progpolymsci.2013.05.00810.1016/j.progpolymsci.2013.05.008 ↗
6. 10.1016/j.memsci.2007.09.05910.1016/j.memsci.2007.09.059 ↗
7. 10.1021/nn101400610.1021/nn1014006 ↗
8. 10.1021/nn800872810.1021/nn8008728 ↗
9. 10.3390/jfb1301000210.3390/jfb13010002 ↗
10. Schalau G. · 2018 · 94
11. 10.1002/marc.20140010410.1002/marc.201400104 ↗
12. 10.1021/acsami.7b0084410.1021/acsami.7b00844 ↗
13. 10.1021/acsami.1c0389510.1021/acsami.1c03895 ↗
14. 10.1021/acsnano.7b0596110.1021/acsnano.7b05961 ↗
15. 10.1016/j.apsusc.2014.12.12110.1016/j.apsusc.2014.12.121 ↗
16. 10.1021/acsami.1c0919410.1021/acsami.1c09194 ↗
17. 10.1016/j.apsusc.2016.10.15310.1016/j.apsusc.2016.10.153 ↗
18. 10.1038/micronano.2017.7310.1038/micronano.2017.73 ↗
19. 10.1021/acsami.8b2240010.1021/acsami.8b22400 ↗
20. 10.1016/j.compscitech.2021.10914810.1016/j.compscitech.2021.109148 ↗
21. 10.1021/acsami.7b1762210.1021/acsami.7b17622 ↗
22. 10.1002/smll.20190016210.1002/smll.201900162 ↗
23. 10.1088/2057-1976/aa91fb10.1088/2057-1976/aa91fb ↗
24. 10.1063/1.161835810.1063/1.1618358 ↗
25. Launer P. · 1987
26. 10.1021/ma049747q10.1021/ma049747q ↗
27. 10.1021/la903445x10.1021/la903445x ↗
28. 10.1116/1.57383310.1116/1.573833 ↗
29. 10.1016/j.surfin.2021.10125610.1016/j.surfin.2021.101256 ↗
30. 10.1016/0969-806X(95)00166-U10.1016/0969-806X(95)00166-U ↗
31. 10.1023/B:HIEC.0000027657.20482.a510.1023/B:HIEC.0000027657.20482.a5 ↗
32. Stankova N. · 2018 · 992 · 012051
33. Chastain J. · 1992
34. 10.1002/sia.263410.1002/sia.2634 ↗
35. 10.1006/jcis.2002.859410.1006/jcis.2002.8594 ↗
36. 10.1016/j.snb.2003.09.02210.1016/j.snb.2003.09.022 ↗
37. 10.1016/S0376-7388(00)00471-310.1016/S0376-7388(00)00471-3 ↗
38. 10.1016/j.apsusc.2008.02.08710.1016/j.apsusc.2008.02.087 ↗
39. 10.1016/j.mee.2011.02.08410.1016/j.mee.2011.02.084 ↗
40. 10.1002/pssc.20098241910.1002/pssc.200982419 ↗
41. 10.1016/S0032-3861(00)00039-210.1016/S0032-3861(00)00039-2 ↗
42. 10.1016/j.orgel.2018.10.02710.1016/j.orgel.2018.10.027 ↗
43. 10.1021/nl201764b10.1021/nl201764b ↗
44. 10.1021/acsami.9b0027410.1021/acsami.9b00274 ↗
45. 10.1364/OE.46401110.1364/OE.464011 ↗
46. 10.1016/j.ijpharm.2015.01.05010.1016/j.ijpharm.2015.01.050 ↗
47. 10.1021/ac991395b10.1021/ac991395b ↗
48. 10.1039/C9LC00039A10.1039/C9LC00039A ↗
49. 10.1016/j.ejpb.2016.03.02610.1016/j.ejpb.2016.03.026 ↗
50. 10.1016/j.memsci.2004.12.01710.1016/j.memsci.2004.12.017 ↗